 |
 |
 |
 |
 |
|
|
| Article 1 to 10 out of 14 concerning Accelrys, Inc.
|
-
Accelrys, Inc. Names Max Carnecchia To Serve As Chief Executive Officer And President
(17 Jun 2009)
Accelrys, Inc. announced that its Board of Directors has named Scipio "Max” Carnecchia to serve as the Company’s Chief Executive Officer and President. Mr. Carnecchia has also been appointed to the Company’s Board of Directors.Mr. Carnecchia comes ...
-
Accelrys, Johnson Matthey and CMR Form Consortium for Alternative Energy Research
(21 May 2007)
Fuel Cell Consortium Result of Award from United Kingdom's Department of Trade and Industry (DTI) for the Automated Design of New Materials for Fuel Cell Catalysts
Accelrys, Inc. together with CMR Fuel Cells and Johnson Matthey Plc, announced the formation of a UK-based Research Consortium. Funding has been awarded through DTI's Technology Programme competition. The DTI will award the Consortium a total of GBP ...
-
Accelrys Announces Pfizer Inc. as the First Member of the Enterprise Cheminformatics Consortium
(05 Feb 2007)
Consortium to Drive the Evolution of Enterprise Cheminformatics Systems Using Open and Flexible Service-Oriented Architecture
Accelrys, Inc. announced the addition of Pfizer to the Accelrys Enterprise Cheminformatics Consortium. The Consortium will be a collaborative software development project led by Accelrys in partnership with a group of commercial member ...
-
Accelrys Nanotechnology Consortium Adds Seven Members, Delivers First Computer-Aided Nanodesign Software Solution
(12 Sep 2005)
Accelrys, Inc. announced the addition of seven new members to the Accelrys Nanotechnology Consortium, as well as the introduction of ONETEP, the first consortium-developed software application. The Consortium brings together leaders from industry, ...
-
SciTegic Announces Expanded Commitment to Pipeline Pilot at Unileve
(08 Mar 2005)
SciTegic, Inc., a wholly owned subsidiary of Accelrys, Inc., announced the sale of a multi-year license of Pipeline Pilot software to Unilever. SciTegic's data pipelining platform is now deployed at four Unilever sites across Europe and the U.S. ...
-
Accelrys Opens New UK Headquarters
(22 Jul 2002)
New Facility to Serve as Base for European Operations
SAN DIEGO, July 19 - Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc, today announces the opening of its new European headquarters in Cambridge, England. The headquarters will be the base for Accelrys' European operations, and will ...
-
Accelrys launches first series of Discovery Studio applications
(27 Jun 2002)
Major milestone reached in effort to deliver an integrated informatics, modeling and simulation platform to speed pharmaceutical discovery
San Diego, CA, June 26 2002 Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc., today announced the first suite of Windows®-based bioinformatics and chemistry applications for its Discovery Studio™ platform. Discovery Studio is designed ...
-
Accelrys announces the release of software für efficient processing and analysis of NMR (nuclear magnetic resonance)
(16 Apr 2002)
San Diego, CA, Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc., announces the release of FELIX Desktop 2002, the new PC version of FELIX. FELIX is a widely used software package for off-line data processing, spectral visualization and ...
-
ACCELRYS ANNOUNCES TOPKAT UPDATE FOR HIGH THROUGHPUT TOXICITY PROFILING
(21 Dec 2001)
Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP), today announced the release of TOPKAT BATCH and Version 6.1 of TOPKAT, a leading program for the in silico estimation of toxicological properties of small molecules ...
-
ACCELRYS ANNOUNCES RELEASE OF SOFTWARE FOR PREDICTING ADME IN EARLY DRUG DISCOVERY
(09 Oct 2001)
Accelrys (a subsidiary of Pharmacopeia Inc., NASDAQ: PCOP) announces the release of C2.ADME, part of the Cerius2® simulation software environment. C2.ADME offers chemists easy access to powerful and validated computational models for predicting ...
 |
|
|
|
|